In patients without EGFR or ALK mutations, the reported median OS ranged from 7.8 to 10 months for non-squamous NSCLC and from 6.5 to 8.5 months for patients with squamous NSCLC [29,53]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.